218 related articles for article (PubMed ID: 3957435)
1. Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus.
Haag R
Infection; 1986; 14(1):38-43. PubMed ID: 3957435
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
Guenthner SH; Wenzel RP
Antimicrob Agents Chemother; 1984 Aug; 26(2):268-9. PubMed ID: 6237606
[TBL] [Abstract][Full Text] [Related]
3. Gentamicin- and methicillin-resistant, clinical isolates of Staphylococcus aureus: comparative in vitro and in vivo efficacy of alternative antimicrobial drugs.
Traub WH; Spohr M; Bauer D
Chemotherapy; 1984; 30(2):102-12. PubMed ID: 6559664
[TBL] [Abstract][Full Text] [Related]
4. Methicillin resistance in Staphylococcus aureus with particular reference to Victorian strains.
Harvey K; Pavillard R
Med J Aust; 1982 May; 1(11):465-7. PubMed ID: 7048040
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
Apisarnthanarak A; Mundy LM
Int J Infect Dis; 2007 May; 11(3):283-4. PubMed ID: 16876452
[No Abstract] [Full Text] [Related]
6. [Severe methicillin-resistant Staphylococcus aureus infections. Emergence of resistance to fusidic acid or fosfomycin during treatment with continuous infusion of vancomycin].
Georges B; Brown L; Mazerolles M; Decun JF; Cougot P; Archambaud M; Suc C; Andrieu P; Virenque C
Presse Med; 1997 Apr; 26(11):502-6. PubMed ID: 9137379
[TBL] [Abstract][Full Text] [Related]
7. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Drugeon HB; Caillon J; Juvin ME
J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Graninger W; Leitha T; Havel M; Georgopoulos A
Infection; 1984; 12(4):293-5. PubMed ID: 6092279
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo study of fosfomycin in methicillin-resistant Staphylococcus aureus septicaemia.
Lau WY; Teoh-Chan CH; Fan ST; Lau KF
J Hyg (Lond); 1986 Jun; 96(3):419-23. PubMed ID: 3637200
[TBL] [Abstract][Full Text] [Related]
10. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
Schrenzel J; Harbarth S; Schockmel G; Genné D; Bregenzer T; Flueckiger U; Petignat C; Jacobs F; Francioli P; Zimmerli W; Lew DP;
Clin Infect Dis; 2004 Nov; 39(9):1285-92. PubMed ID: 15494904
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of daptomycin combinations with rifampicin, gentamicin, fosfomycin and fusidic acid against MRSA strains.
Aktas G; Derbentli S
J Glob Antimicrob Resist; 2017 Sep; 10():223-227. PubMed ID: 28735049
[TBL] [Abstract][Full Text] [Related]
13. Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus.
Rayner C; Munckhof WJ
Intern Med J; 2005 Dec; 35 Suppl 2():S3-16. PubMed ID: 16271060
[TBL] [Abstract][Full Text] [Related]
14. Teicoplanin, vancomycin, rifampicin: in-vivo and in-vitro studies with Staphylococcus aureus.
Carper HT; Sullivan GW; Mandell GL
J Antimicrob Chemother; 1987 May; 19(5):659-62. PubMed ID: 2956229
[TBL] [Abstract][Full Text] [Related]
15. [Staphylococcus aureus resistant to cloxacillin: treatment with fosfomycin-rifampicin].
Wolff M; Nercelles P; Pepay K
Rev Med Chil; 1984 Jul; 112(7):665-71. PubMed ID: 6569621
[No Abstract] [Full Text] [Related]
16. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus.
O'Neill AJ; Cove JH; Chopra I
J Antimicrob Chemother; 2001 May; 47(5):647-50. PubMed ID: 11328777
[TBL] [Abstract][Full Text] [Related]
17. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
Graninger W; Leitha T; Breyer S; Francesconi M; Lenz K; Georgopoulos A
Drugs Exp Clin Res; 1985; 11(1):23-7. PubMed ID: 3869801
[TBL] [Abstract][Full Text] [Related]
18. [Susceptibility of drug-resistant staphylococci isolated from different parts of the ocular anterior segment to common ophthalmic antibiotics].
Yue J; Wang CM; Lyu JX; Jian SJ; Niu YY; Liu SS; Sun ST; Han L; Zhang HM
Zhonghua Yan Ke Za Zhi; 2022 Aug; 58(8):598-605. PubMed ID: 35959604
[No Abstract] [Full Text] [Related]
19. Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Fantin B; Leclercq R; Duval J; Carbon C
Antimicrob Agents Chemother; 1993 Nov; 37(11):2466-9. PubMed ID: 8285635
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
Unowsky J; Chandrasekar PH; DeLorenzo W; Levine DP
Chemotherapy; 1986; 32(6):499-505. PubMed ID: 3492342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
